Familial aggregation of ovarian cancer occurs in the Israeli Jewish population.doi:10.1097/00006250-199102000-00023MENCZER, JOSEPHBEN-BARUCH, GILADObstetrics & GynecologyMenczer J, Ben-Baruch G. Familial ovarian cancer in Israeli Jewish women. Obstet Gynecol 1991;77:276-277....
9 of the 13 Jewish women (69%) with a BRCA mutation had BSO, as did 1 of 2 non-Jewish women. These preliminary data suggest that women with BRCA mutations participate in appropriate preventive strategies for ovarian cancer; most choosing prophylactic BSO. Jewish patients were more likely to ...
In the US, ovarian cancer is the second most common gynecologic cancer and has the highest mortality rate of any gynecologic cancer. Incidence increases with age (peak incidence at 55–64 years of...
Ovarian cancer accounts for approximately 4% of cancer related deaths worldwide with an estimated number of 131000 patients dying from this disease in 2000 (World Health Report 2002). There is a high incidence in Northern Europe and in the United States,
Adjusted for age, race, duration of oral contraceptive use, and family history of ovarian cancer. Among women who had a history of infertility, use of fertility drugs was reported by 44 (24%) of 182 controls and 38 (17%) of 226 cases. Among infertile women, ever use of fertility drugs...
Austin S, Martin MY, Kim Y, Funkhouser EM, Partridge EE, Pisu M (2012) Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States. Health Serv Res. doi:10.1111/1475-6773.12012 PubMedGoogle Scholar ...
Women with inherited mutations in the BRCA1 or BRCA2 genes have increased lifetime risks for developing breast and/or ovarian cancer and may develop these cancers around the age of 30 years. Therefore, prevention of breast and ovarian cancer in these women may need to start relatively early in...
The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives Hum Mut, 22 (2003), p. 104 View in ScopusGoogle Scholar 16 Moslehi R, Chu W, Karlan B, et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian ...
Results were similar for PFS and ovarian cancer-specific survival. In analyses stratified by histologic subtype, associations were strongest for women with low-grade serous (pHR: 1.12 per 5 kg m−2) and endometrioid subtypes (pHR: 1.08 per 5 kg m−2), and more modest for the ...
December 2010 Available Online 4 January 2011 Abbreviations: AGR2, anterior gradient 2; agt, angiotensinogen; RT-CES, real-time cell electronic sensing system; THBS1, thrombo- spondin 1; vegf A, vascular endothelial growth factor A Abstract Ovarian cancer is a leading cause of death in women....